Cepheid Stock

Stocks

01/05/12

15/02/17	Cepheid : Announces FDA Clearance Of Xpert® Xpress Flu And Xpert Xpress Flu/RSV	PU
05/11/16	Cepheid : Danaher Completes Acquisition Of Cepheid	PR
27/10/16	Cepheid : 30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US	PR
24/10/16	Cepheid : Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation	PR
06/10/16	Cepheid : New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring	PR

06/09/16	Danaher : renforce dans les diagnostics avec Cepheid
06/09/16	Danaher : acquiert le spécialiste des diagnostics Cepheid

Manager	Title	Age	Since
Charles Mwangi DFI	Director of Finance/CFO	59	01/07/2023
Anupama Mokkapati COO	Chief Operating Officer	-	01/11/2021
Laurent Bellon COO	Chief Operating Officer	-	01/08/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CEPHEID	-.--%	+0.36%	-	-	0
THERMO FISHER SCIENTIFIC, INC.	+1.12%	+0.29%	+24.93%	+55.29%	262B
DANAHER CORPORATION	+2.09%	+0.37%	+9.87%	+18.73%	165B
INTUITIVE SURGICAL, INC.	+9.38%	+8.54%	-10.53%	+73.09%	167B
BOSTON SCIENTIFIC CORPORATION	+5.33%	+7.99%	-53.64%	-12.77%	66.41B
EDWARDS LIFESCIENCES CORPORATION	+4.39%	+8.27%	+18.09%	+48.16%	57.28B
SIEMENS HEALTHINEERS AG	-2.32%	+2.66%	-2.16%	-7.44%	56.02B
AGILENT TECHNOLOGIES, INC.	+0.97%	-2.37%	+21.28%	+62.51%	49.95B
VEEVA SYSTEMS INC.	+2.45%	-2.26%	+5.84%	+59.63%	50.29B
WATERS CORPORATION	+1.67%	-1.95%	+27.29%	+79.51%	45.94B
Average	+0.44%	+2.17%	+4.55%	+41.86%	102.22B
Weighted average by Cap.	+0.09%	+2.34%	+6.91%	+44.62%